Skip to main content
Figure 2 | BMC Cancer

Figure 2

From: Prognostic value of α-fetoprotein and des-γ-carboxy prothrombin responses in patients with hepatocellular carcinoma treated with transarterial chemoembolization

Figure 2

Progression-free survival (PFS) and overall survival (OS) curves of DCP responder and non-responder. Both PFS and OS were not significantly different between DCP responder and non-responder (7.8 vs.7.3 months; log rank test, P = 0.755 for PFS (A) and 34.9 vs. 23.2 months; log rank test, P = 0.203 for OS (B)).

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us